Stay updated on Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Footer updates: added 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.
    Difference
    0.2%
    Check dated 2025-12-23T09:18:35.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page shows a revision banner updating from v3.2.0 to v3.3.2, with no visible changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T18:27:22.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The government funding status banner on the page footer was removed.
    Difference
    0.6%
    Check dated 2025-11-17T17:57:50.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page layout and styling were updated; core content such as study details and eligibility criteria remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T12:39:08.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    - Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.
    Difference
    8%
    Check dated 2025-10-05T16:45:46.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    - Updated revision from v3.0.2 to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-28T09:52:10.000Z thumbnail image

Stay in the know with updates to Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial page.